Prevalence and Characteristics of Low-renin Hypertension in a Primary Care Population.

hypertension low-renin prevalence

Journal

Journal of the Endocrine Society
ISSN: 2472-1972
Titre abrégé: J Endocr Soc
Pays: United States
ID NLM: 101697997

Informations de publication

Date de publication:
01 Jul 2024
Historique:
received: 18 04 2024
medline: 3 7 2024
pubmed: 3 7 2024
entrez: 3 7 2024
Statut: epublish

Résumé

Low-renin hypertension is an underrecognized subtype of hypertension with specific treatment options. This study aims to identify the prevalence in primary care and to compare patient characteristics to those with normal-renin hypertension and primary aldosteronism (PA). In a cohort study, patients with treatment-naïve hypertension were screened for PA with plasma aldosterone and direct renin concentrations. Patients with an elevated aldosterone-to-renin ratio [≥70 pmol/mU (≥2.5 ng/dL:mU/L)] underwent confirmatory testing. All screened patients were then classified as having (1) normal-renin hypertension, (2) low-renin hypertension (direct renin concentration <10mU/L (plasma renin activity ∼<1 ng/mL/hour) and not meeting the criteria for PA), or (3) confirmed PA. Of the 261 patients, 69 (26.4%) had low-renin hypertension, 136 (51.9%) had normal renin hypertension, and 47 (18.0%) had PA. Patients with low-renin hypertension were older and more likely to be female compared to normal-renin hypertension (57.1 ± 12.8 years vs 51.8 ± 14.0 years, At least a quarter of treatment-naïve hypertensive patients in primary care had a low direct renin concentration but did not meet the criteria for PA. Patient characteristics were similar, aside from a lower aldosterone concentration compared to patients with normal-renin hypertension and PA. Further research is needed to understand the underlying pathophysiology of low-renin hypertension and the optimal first-line treatment.

Identifiants

pubmed: 38957654
doi: 10.1210/jendso/bvae113
pii: bvae113
pmc: PMC11215789
doi:

Types de publication

Journal Article

Langues

eng

Pagination

bvae113

Informations de copyright

© The Author(s) 2024. Published by Oxford University Press on behalf of the Endocrine Society.

Auteurs

Sonali S Shah (SS)

Centre for Endocrinology and Metabolism, Hudson Institute of Medical Research, Clayton, Victoria 3168, Australia.
Department of Endocrinology, Monash Health, Clayton, Victoria 3168, Australia.
Department of Molecular and Translational Science, Monash University, Clayton, Victoria 3168, Australia.

Renata Libianto (R)

Centre for Endocrinology and Metabolism, Hudson Institute of Medical Research, Clayton, Victoria 3168, Australia.
Department of Endocrinology, Monash Health, Clayton, Victoria 3168, Australia.

Stella May Gwini (SM)

Centre for Endocrinology and Metabolism, Hudson Institute of Medical Research, Clayton, Victoria 3168, Australia.
School of Public Health and Preventive Medicine, Monash University, Clayton, Victoria 3168, Australia.

Grant Rusell (G)

Department of General Practice, Monash University, Notting Hill, Victoria 3168, Australia.

Morag J Young (MJ)

Centre for Endocrinology and Metabolism, Hudson Institute of Medical Research, Clayton, Victoria 3168, Australia.
Baker Heart and Diabetes Institute, Prahran, Victoria 3004, Australia.

Peter J Fuller (PJ)

Centre for Endocrinology and Metabolism, Hudson Institute of Medical Research, Clayton, Victoria 3168, Australia.
Department of Endocrinology, Monash Health, Clayton, Victoria 3168, Australia.
Department of Molecular and Translational Science, Monash University, Clayton, Victoria 3168, Australia.

Jun Yang (J)

Centre for Endocrinology and Metabolism, Hudson Institute of Medical Research, Clayton, Victoria 3168, Australia.
Department of Endocrinology, Monash Health, Clayton, Victoria 3168, Australia.
Department of Molecular and Translational Science, Monash University, Clayton, Victoria 3168, Australia.

Classifications MeSH